The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CVM-1118: An oral anti-vasculogenic mimicry (VM) agent in combination with nivolumab in patients with unresectable advanced hepatocellular carcinoma (HCC)—A phase IIa study.
 
Chia Jui Yen
No Relationships to Disclose
 
Yi-Hsiang Huang
Honoraria - AstraZeneca; Gilead Sciences
 
Kun-Yun Yeh
No Relationships to Disclose
 
Pei-Jer Chen
No Relationships to Disclose
 
Sheng-Nan Lu
No Relationships to Disclose
 
John Gutheil
Employment - SciQuus Oncology
Leadership - SciQuus Oncology
Stock and Other Ownership Interests - SciQuus Oncology
Patents, Royalties, Other Intellectual Property - Listed as an inventor on a patient from Cleave Biotechnology
 
Teresa J. Melink
Employment - SciQuus Oncology
Leadership - SciQuus Oncology
Stock and Other Ownership Interests - SciQuus Oncology
 
Yen-Ling Chen
Employment - TaiRx, Inc.
Stock and Other Ownership Interests - TaiRx, Inc.
Travel, Accommodations, Expenses - TaiRx, Inc.
 
Chun-Man Chen
Employment - TaiRx, Inc.
Stock and Other Ownership Interests - TaiRx, Inc.
 
Ting-Yu (Tiffany) Chao
Employment - TaiRx, Inc.
 
Yi-Wen Chu
Employment - TaiRx, Inc.
Leadership - TaiRx, Inc.
Stock and Other Ownership Interests - TaiRx, Inc.
Patents, Royalties, Other Intellectual Property - TaiRx, Inc.
 
Du-Shieng Chien
Employment - TaiRx, Inc.
Leadership - TaiRx, Inc.
Stock and Other Ownership Interests - TaiRx, Inc.
Consulting or Advisory Role - Efficient Pharma Management Corp.